Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List

By Joel Lim, InvestorPlace Contributor
Don’t miss out on these three strong buy biotech stocks that are leaders to add to your portfolio for Q2 this year.

3 Cannabis Stocks to Buy Before the Coming Pre-Election Rally

By Faisal Humayun, InvestorPlace Contributor
These are the attractive cannabis stocks to buy and represents companies positioned for healthy growth and EBITDA margin expansion.

The 2025 Double: 3 Stocks Poised to Deliver 100% Gains in Just 12 Months

By Alex Sirois, InvestorPlace Contributor
Let's review what Wall Street analysts believe are potentially the stocks to double over the next 12 months.

Cannabis Stocks Heat Up Again Ahead of German Rollout

By Shrey Dua, InvestorPlace Senior Financial News Reporter
Cannabis stocks continue to soar as Germany's marijuana decriminalization law goes into action this Monday, April 1.

Harnessing AI for Drug Discovery: Top 3 Stocks to Watch

By Joey Frenette, InvestorPlace Contributor
As biotech innovators look to AI to smoothen out the drug discovery process, the leaders in the scene could stand to benefit greatly.

Why Is Viking Therapeutics (VKTX) Stock Up 24% Today?

By William White, InvestorPlace Writer
Viking Therapeutics stock is rising higher on Tuesday as investors in VNKTX shares react to positive Phase 1 clinical trial results.

3 Cannabis Stocks That Could Be Multibaggers in the Making: March Edition

By Faisal Humayun, InvestorPlace Contributor
These are the undervalued cannabis stocks to buy as they represent companies poised for healthy growth and margin expansion.

Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?

By William White, InvestorPlace Writer
NeuBase Therapeutics stock is down on Tuesday as NBSE investors react to details concerning an upcoming special shareholder meeting.

Why Is Check-Cap (CHEK) Stock Up 44% Today?

By William White, InvestorPlace Writer
Check-Cap stock is up on Tuesday with heavy trading as CHEK investors react to news of a business combination with Nobul AI.

Why Is Stoke Therapeutics (STOK) Stock Up 99% Today?

By William White, InvestorPlace Writer
Stoke Therapeutics stock is up on Tuesday as STOK shares see heavy trading alongside recent positive clinical trial data.

3 Growth Stocks to Buy at 52-Week Lows in March

By Muslim Farooque, InvestorPlace Contributor
Wager on these growth stocks to buy at 52-week lows offering robust investment potential ahead for savvy investors.

3 Biotech Stocks to Buy for the Next Bull Run: March 2024

By Mohammed Saqib, InvestorPlace Contributor
These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run.

3 Retirement Stocks to Buy at a 52-Week Low in March

By Michael Que, InvestorPlace Contributor
Investing in these retirement stocks to buy at one-year lows presents a prime opportunity for long-term gains.

Go Contrarian: 3 Analyst ‘Sells’ That Could Be Buys in Disguise

By Josh Enomoto, InvestorPlace Contributor
When assessing the viability of contrarian stocks, it’s generally better to go against the crowd, not against analysts. Retail investors can sometimes get sucked into…

3 Ridiculously Enticing Stocks to Buy for Under a Buck

By Josh Enomoto, InvestorPlace Contributor
Let’s keep it real in this joint – you should generally avoid stocks under $1. Yes, they’re “cheap” but that’s not necessarily a good thing.…

Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich

By Ian Cooper, InvestorPlace Contributor
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.

Why Is Landos Biopharma (LABP) Stock Up 168% Today?

By William White, InvestorPlace Writer
Landos Biopharma stock is up on Monday as LABP investors learn about a massive acquisition deal with AbbVie that values it at $137.5 million.

Why Is Ocugen (OCGN) Stock Up 20% Today?

By William White, InvestorPlace Writer
Ocugen stock is heading higher on Friday as investors in OCGN shares react to a dismissed class action lawsuit against the company.

Hot Stocks: The 3 Best Opportunities for Investing in the S&P 500           

By Muslim Farooque, InvestorPlace Contributor
Invest in these three top S&P 500 stocks to buy offering healthy upside as the Fed signals triple rate cut later this year.
Load More Articles